Abstract
TRPC5 channels are Ca2+-permeable nonselective cation channels activated by G-protein-coupled receptors, although the mechanisms responsible for channel activation and regulation are poorly understood. Carbachol-activated TRPC5 currents were recorded by the whole-cell patch clamp technique from human embryonic kidney 293 cells transiently transfected with TRPC5 and the M1 muscarinic receptor. Some published studies of TRPC5 currents have included ATP and/or GTP in the patch pipette, whereas others used an ATP- and GTP-free pipette solution. We initially included these two nucleotides in the patch pipette but found that TRPC5 currents were absent or were very small. Recordings made with an ATP- and GTP-free pipette solution produced large and robust TRPC5 currents. Under these conditions, treatment of cells with Pasteurella multocida toxin, a selective inhibitor of Gαq, almost abolished TRPC5 currents indicating that Gαq is necessary for activation of TRPC5 by the M1 receptor. To study the effect of intracellular ATP on TRPC5 channels, an intracellular perfusion system was used. Perfusion of ADP or control pipette solution had no effect, whereas perfusion of ATP or AMP-PNP, a nonhydrolyzable analog of ATP, significantly inhibited TRPC5 currents. Thus, the effects of ATP have structural specificity and probably involve a direct effect on the channel rather than a phosphorylation-mediated effect. The activity of TRPC5 channels may be linked to cellular metabolism via changes in ATP levels and could be involved in Ca2+ overload occurring after ischemia when ATP is depleted.
Footnotes
-
This work was supported by United States Public Health Service grant NS35047.
-
ABBREVIATIONS: TRPC1, -3, -4, or -5, canonical transient receptor potential channel, subfamily 1, 3, 4, or 5, respectively; TRPM4b or 7, melastatin transient receptor potential, subfamily 4b or 7, respectively; GPCR, G-protein-coupled receptor; PLC, phospholipase C; eGFP, enhanced green fluorescent protein; HEK, human embryonic kidney; PMT, Pasteurella multocida toxin; I-V, current-voltage; AMP-PNP, adenyl-5′-yl imidodiphosphate; BAPTA, 1,2-bis(O-aminophenoxy)ethane-N,N,N′,N′-tetraacetate; PIP2, phosphatidylinositol 4,5-bisphosphate; Kir, inward rectifier potassium channel; KATP, ATP-sensitive potassium channel.
-
↵
The online version of this article (available at http://molpharm.aspetjournals.org) contains supplemental material.
- Received August 14, 2007.
- Accepted October 9, 2007.
- The American Society for Pharmacology and Experimental Therapeutics
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|